HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alain Bel Louis P. Perrault Bouchaib Faris Philippe Menasché Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bel, A. Articles by Menasché, P. Search for Related Content PubMed PubMed Citation Articles by Bel, A. Articles by Menasché, P.

Ann Thorac Surg 1998;66:148-152
© 1998 The Society of Thoracic Surgeons

---

Original articles: cardiovascular

Inhibition of the pacemaker current: a bradycardic therapy for off-pump coronary operations

^a Department of Cardiovascular Surgery and INSERM U-127, Hôpital Lariboisière, Paris, and the Servier Research Institute, Suresnes, France

Accepted for publication March 5, 1998.

Address reprint requests to Dr Menasché, Department of Cardiovascular Surgery, Hôpital Lariboisière, 2, rue Ambroise Paré, 75010 Paris, France

Background. The accurate performance of coronary anastomoses on the beating heart requires some form of myocardial immobilization that can be achieved pharmacologically. Different classes of drugs can be used to induce bradycardia, but the most effective in this setting of off-pump operation has not yet been determined.

Methods. Fifty-six isolated buffer-perfused rabbit hearts were divided into seven equal groups. Control hearts were continuously perfused throughout the experimental time course. A second group of hearts underwent 60 minutes of potassium arrest (at 37°C) followed by 1 hour of reperfusion. The following pharmacologic approaches were tested in the remaining five groups: short-acting ß-blockade (esmolol, 6 x 10^-3 mol/L and 3 x 10^-4 mol/L), opening of adenosine triphosphate-dependent potassium channels (nicorandil, 10^-3 mol/L and 10^-5 mol/L), and inhibition of the pacemaker current, which largely accounts for the diastolic depolarization of sinoatrial node cells (S 16257-2, 3 x 10^-6 mol/L). Each drug was infused at a constant rate for 60 minutes, after which hearts were perfused for 1 additional hour with drug-free buffer. Heart rate and isovolumic measurements of function and coronary flow were serially taken during and after drug infusion.

Results. The worst recovery of systolic and, moreover, diastolic function was yielded by potassium arrest. Neither esmolol nor nicorandil was able to induce a significant bradycardia. However, nicorandil did not impair function which, conversely, was markedly depressed after esmolol therapy. Significant bradycardia (p < 0.0001 versus corresponding baseline values and versus all other groups) was only achieved with pacemaker current inhibition, which was otherwise associated with an excellent preservation of contractility, diastolic function, and coronary flow.

Conclusions. Inhibition of the pacemaker current seems to be an effective approach for inducing intraoperative bradycardia without compromising left ventricular function or flow.

This article has been cited by other articles:

				T. Watanabe, S. Omata, M. Odamura, M. Okada, Y. Nakamura, and H. Yokoyama Three-dimensional quantification of cardiac surface motion: a newly developed three-dimensional digital motion-capture and reconstruction system for beating heart surgery. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1162 - 1171. [Abstract] [Full Text] [PDF]

				J.-C. Tardif Ivabradine in clinical practice: benefits of If inhibition Eur. Heart J. Suppl., September 1, 2005; 7(suppl_H): H29 - H32. [Abstract] [Full Text] [PDF]

				K. Fox Ivabradine -- a selective and specific If inhibitor: efficacy and safety in stable angina Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G36 - G45. [Abstract] [PDF]

				J. S. Borer, K. Fox, P. Jaillon, G. Lerebours, and for the Ivabradine Investigators Group Antianginal and Antiischemic Effects of Ivabradine, an If Inhibitor, in Stable Angina: A Randomized, Double-Blind, Multicentered, Placebo-Controlled Trial Circulation, February 18, 2003; 107(6): 817 - 823. [Abstract] [Full Text] [PDF]

				C. Hagl, J. D. Galla, S. L. Lansman, D. Fink, C. A. Bodian, D. Spielvogel, and R. B. Griepp Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using prosthetic material contraindicated? Ann. Thorac. Surg., November 1, 2002; 74(5): S1781 - 1785. [Abstract] [Full Text] [PDF]

				V. Falk Manual control and tracking--a human factor analysis relevant for beating heart surgery Ann. Thorac. Surg., August 1, 2002; 74(2): 624 - 628. [Abstract] [Full Text] [PDF]